Researchers develop TIM-3 decoy to enhance CAR-T therapy effectiveness for B-ALL tumors
B-cell Acute Lymphoblastic Leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most common ...
B-cell Acute Lymphoblastic Leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most common ...
A stem cell therapy trial aimed at reducing neuroinflammation in patients with presymptomatic Alzheimer's disease is underway at UTHealth Houston. In ...
Adding immunotherapy to a new type of inhibitor that targets multiple forms of the cancer-causing gene mutation KRAS kept pancreatic ...
Insilico Medicine("Insilico"), a clinical stage generative artificial intelligence (AI)-driven biotechnology company, recently announced that its breakthrough drug candidate for idiopathic ...
What are the challenges of drug development? Drug development is a very challenging and often arduous process with many associated ...
In this interview, industry expert Phillip Mitchell discusses the role of NfL biomarkers in CNS drug discovery, neurodegenerative disease research, ...
Brain metastases are one of the most severe complications of melanoma, the most aggressive type of skin cancer. Researchers at ...
A team of international researchers led by scientists at City of Hope, one of the largest and most advanced cancer ...
The hormone estrogen regulates binge drinking in females, causing them to "pregame" – consume large quantities of alcohol in the ...
Cleveland Clinic researchers have found definitive proof of a kidney microbiome that influences renal health and kidney stone formation, demonstrating ...
Sepoy.net is a perfect place for people who want daily updates on news related to business, technology, entertainment, health, cryptocurrency etc.
Contact: hello@sepoy.net
© 2023 Sepoy.net